REPLIGEN CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.4 USD | +0.94% |
|
-0.40% | -7.46% |
| May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
| May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REPLIGEN CORPORATION | Other Medical Equipment, Supplies & Distribution | +0.99% | -0.40% | -7.46% | +7.46% | +140.16% | 9.21B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RGEN Stock
- Charts Repligen Corporation
- Comparison Chart
